Literature DB >> 11154911

Cut and trim: generating MHC class I peptide ligands.

J W Yewdell1, J R Bennink.   

Abstract

Progress in understanding how peptide ligands are generated for MHC class I molecules took several interesting leaps and twists in the past year. Two independent lines of evidence suggest that most peptides are generated by proteasomal digestion of nascent proteins. The amino-terminally extended cytosolic precursors of an antigenic peptide were identified, bound to a mysterious carrier protein. Knowledge about the role of immunoproteasomes in antigen processing was fortified, cellular locales specialized for proteasomal degradation (and possibly antigenic-peptide production) were discovered and novel cytosolic proteases potentially involved in generating and trimming antigenic peptides were identified. The field is poised for quantitative analysis of the various pathways that contribute to the pool of peptides presented to the immune system by MHC class I molecules.

Mesh:

Substances:

Year:  2001        PMID: 11154911     DOI: 10.1016/s0952-7915(00)00175-8

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  24 in total

1.  Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.

Authors:  Rafaela Holtappels; Doris Thomas; Jürgen Podlech; Matthias J Reddehase
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors:  Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal:  Immunogenetics       Date:  2003-08-30       Impact factor: 2.846

3.  The efficacy of antigen processing is critical for protection against cytomegalovirus disease in the presence of viral immune evasion proteins.

Authors:  Rafaela Holtappels; Doris Thomas; Matthias J Reddehase
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

4.  Species-specific class I gene expansions formed the telomeric 1 mb of the mouse major histocompatibility complex.

Authors:  Toyoyuki Takada; Attila Kumánovics; Claire Amadou; Masayasu Yoshino; Elsy P Jones; Maria Athanasiou; Glen A Evans; Kirsten Fischer Lindahl
Journal:  Genome Res       Date:  2003-04       Impact factor: 9.043

5.  The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism.

Authors:  Shih-Chung Chang; Frank Momburg; Nidhi Bhutani; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

6.  Prediction of supertype-specific HLA class I binding peptides using support vector machines.

Authors:  Guang Lan Zhang; Ivana Bozic; Chee Keong Kwoh; J Thomas August; Vladimir Brusic
Journal:  J Immunol Methods       Date:  2007-01-25       Impact factor: 2.303

7.  Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients.

Authors:  Brian Niland; Gabriella Miklossy; Katalin Banki; William E Biddison; Livia Casciola-Rosen; Antony Rosen; Denis Martinvalet; Judy Lieberman; Andras Perl
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

8.  Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner.

Authors:  B E Gewurz; E W Wang; D Tortorella; D J Schust; H L Ploegh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

9.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  BAG-6 is essential for selective elimination of defective proteasomal substrates.

Authors:  Ryosuke Minami; Atsuko Hayakawa; Hiroki Kagawa; Yuko Yanagi; Hideyoshi Yokosawa; Hiroyuki Kawahara
Journal:  J Cell Biol       Date:  2010-08-16       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.